Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2019-07-08 | WellMarker Bio | Series B | $15.24M | BRIC Investment, CytoGen, HB Investment, Mirae Asset Venture Investment, NH Investment & Securities, and Orbit Partners |
2019-06-24 | Xing Xing | Series A | $5.2M | AlpenRoute Asset Management, Capstone Partners, and Core Investment |